Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BIAF save search
bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
Published: 2022-09-28 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 69.81%
H: 17.5%
C: -18.89%
offering
bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
Published: 2022-09-14 (Crawled : 13:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 37.68%
H: 19.3%
C: -14.74%
lung health flow one
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
Published: 2023-01-24 (Crawled : 15:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 20.13%
H: 108.9%
C: 46.07%
research respiratory trial results publication
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 14.1%
H: 0.01%
C: -7.3%
award patent cancer
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 8.33%
H: 0.0%
C: -5.59%
conference growth
bioAffinity Technologies In the News
Published: 2024-01-08 (Crawled : 14:30) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 7.22%
H: 0.0%
C: -4.88%
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
Published: 2023-03-24 (Crawled : 13:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 5.56%
H: 0.53%
C: -3.68%
report financial results
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 5.49%
H: 0.0%
C: -8.05%
sales
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer - January 23, 2024
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 5.3%
H: 0.0%
C: -2.52%
award patent cancer treatment
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 2.97%
H: 1.92%
C: 0.48%
year financial results
bioAffinity Technologies In The News - January 30, 2024
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 2.5%
H: 0.51%
C: -2.44%
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 2.44%
H: 0.0%
C: -2.38%
lung symposium cancer
Argus Research Initiates Equity Research Report Coverage on Largo Inc. (NasdaqGS: LGO, TSX: LGO)
Published: 2023-03-28 (Crawled : 12:00) - prnewswire.com
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 1.76%
H: 2.03%
C: -6.03%
report research
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
Published: 2023-03-28 (Crawled : 13:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 1.76%
H: 2.03%
C: -6.03%
cypath lung cancer publication
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 1.26%
H: 2.05%
C: 1.32%
research meeting cancer
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 1.05%
H: 14.52%
C: 6.22%
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Published: 2023-11-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 0.6%
H: 0.0%
C: -2.39%
lung cancer
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K
|
|
| O: 0.0%
H: 2.68%
C: -0.36%
lung conference flow results
bioAffinity Technologies Announces Pricing of IPO
Published: 2022-09-01 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.56 -14.67% -17.19% 400K
|
| Email alert
Add to watchlist
technology
WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit
Published: 2022-09-01 (Crawled : 17:00) - prnewswire.com
BIAF | $2.56 -14.67% -17.19% 400K
|
| Email alert
Add to watchlist
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.